UBT251 Injection 4.0 mg

DRUG2 trials

Sponsors

The United Bio-Technology (Hengqin) Co., Ltd.

Conditions

Obesity & OverweightType 2 Diabetes

Phase 3

UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)

Not yet recruitingNCT07648225

The United Bio-Technology (Hengqin) Co., Ltd.Obesity & Overweight

Start: 2026-07-31End: 2027-11-03Target: 600Updated: 2026-06-15

Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone（UNIGUIDE-1）

RecruitingNCT07659574

The United Bio-Technology (Hengqin) Co., Ltd.Type 2 Diabetes

Start: 2026-09-07End: 2027-10-22Target: 360Updated: 2026-09-15